The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Cardiovascular disease as a leading cause of death: how are pharmacists getting involved?
Open accessAbstract
Cardiovascular diseases (CVDs) are a leading cause of death globally. This article explores the evidence surrounding community pharmacist interventions to reduce cardiovascular events and related mortality and to improve the management of CVD risk factors. We summarize a range of systematic reviews and leading randomized controlled trials and provide critical appraisal. Major observations are that very few trials directly measure clinical outcomes, potentially owing to a range of challenges in this regard. By contrast, there is an extensive, high-quality evidence to suggest that improvements can be achieved for key CVD risk factors such as hypertension, dyslipidemia, tobacco use, and elevated hemoglobin A1c. The heterogeneity of interventions tested and considerable variation of the context under which implementation occurred suggest that caution is warranted in the interpretation of meta-analyses. It is highly important to generate evidence for pharmacist interventions in developing countries where a majority of the global CVD burden will be experienced in the near future. A growing capacity for clinical registry trials and data linkage might allow future research to collect clinical outcomes data more often.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Global estimates of the prevalence of diabetes for 2010 and 2030
Shaw, J. E., Sicree, R. A., & Zimmet, P. Z. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.10.007 · Cited by 7,216
Chronic kidney disease: global dimension and perspectives
Jha, V., Garcia-Garcia, G., Iseki, K., Li, Z., Naicker, S., Plattner, B., Saran, R., Wang, A. Y.-M., & Yang, C.-W. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60687-x · Cited by 4,383
Yusuf, S., Hawken, S., & Ounpuu, S. (2004) · ACC Current Journal Review · doi:10.1016/j.accreview.2004.11.072 · Cited by 1,141
Cranor, C. W., Bunting, B. A., & Christensen, D. B. (2003) · Journal of the American Pharmaceutical Association (1996) · doi:10.1331/108658003321480713 · Cited by 728
Machado, M., Bajcar, J., Guzzo, G. C., & Einarson, T. R. (2007) · Annals of Pharmacotherapy · doi:10.1345/aph.1k311 · Cited by 378
The Potency of Team-Based Care Interventions for Hypertension: A Meta-analysis
Carter, B. L., Rogers, M., Daly, J., Zheng, S., & James, P. A. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.316 · Cited by 354
Santschi, V., Chiolero, A., Colosimo, A. L., Platt, R. W., Taffé, P., Burnier, M., Burnand, B., & Paradis, G. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.113.000718 · Cited by 349
Shared decision making: what do clinicians need to know and why should they bother?
Hoffmann, T. C., Légaré, F., Simmons, M. B., McNamara, K., McCaffery, K., Trevena, L. J., Hudson, B., Glasziou, P. P., & Del Mar, C. B. (2014) · Medical Journal of Australia · doi:10.5694/mja14.00002 · Cited by 343
Self-citation
Cited by
Adiponectin, Leptin and Cardiovascular Disorders
Zhao, S., Kusminski, C. M., & Scherer, P. E. (2021) · Circulation Research · doi:10.1161/circresaha.120.314458 · Cited by 373
Transfer learning techniques for medical image analysis: A review
Kora, P., Ooi, C. P., Faust, O., Raghavendra, U., Gudigar, A., Chan, W. Y., Meenakshi, K., Swaraja, K., Plawiak, P., & Rajendra Acharya, U. (2022) · Biocybernetics and Biomedical Engineering · doi:10.1016/j.bbe.2021.11.004 · Cited by 367
Ergir, E., Oliver-De La Cruz, J., Fernandes, S., Cassani, M., Niro, F., Pereira-Sousa, D., Vrbský, J., Vinarský, V., Perestrelo, A. R., Debellis, D., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-22225-w · Cited by 99
Metadata
- Authors
- Mc Namara, K., Alzubaidi, H., & Jackson, J. K.
- Venue
- Integrated Pharmacy Research and Practice
- Publisher
- Informa UK Limited
- Published
- 2019-02
- Volume
- Volume 8
- Pages
- 1-11
- ISSN
- 2230-5254 (ISSN-L)
- OpenAlex
- W2911490596
- Cited by
- 410
- References
- 62
- FWCI
- 50.71
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cardiovascular disease as a leading cause of death: how are pharmacists getting involved? https://app.cochat.ai/papers/10.2147/iprp.s133088
- The paper
- Mc Namara, K., Alzubaidi, H., & Jackson, J. K. (2019). Cardiovascular disease as a leading cause of death: how are pharmacists getting involved? Integrated Pharmacy Research and Practice. https://doi.org/10.2147/iprp.s133088
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.